Flu season is coming: What to know about new vaccine, when to get your shot and more

A new messenger RNA (mRNA) influenza vaccine has received FDA approval and is slated to appear in retail pharmacies. The Press Democrat reports that the vaccine will be stocked soon at local CVS and Walgreens locations, while The Frederick News-Post notes its presence at three pharmacies in the Frederick County area. The approval applies to adults 50 and older, according to wowo.com, and 2 Minute Medicine states that the mRNA shot outperforms the standard‑dose vaccination. Technology Networks highlights that the vaccine generated a diverse antibody response in adults. Coverage of the rollout is spread across a mix of national and regional outlets. RTTNews and the American Journal of Managed Care list the approval among other recent FDA actions.

Technology Networks and Futurity provide scientific commentary on the vaccine’s performance, with Futurity offering a consumer‑focused guide to what readers should know. Local health‑focused sites such as cbs19news.com, Miami’s Community News, Georgia Coastal Health District, MessageMedia.co, and KSNV urge residents to get the shot as the flu season approaches. Opinion pieces appear in the Athens Daily Review and The San Fernando Valley Sun, warning of low vaccination rates. The timing coincides with the annual rise in influenza activity, a period traditionally marked by public health campaigns urging early vaccination. The new mRNA platform follows the success of COVID‑19 mRNA vaccines and promises a stronger immune response, as indicated by the diverse antibody findings. However, todayville.com reports that the CDC removed the vaccine from its recommendations two weeks after a reanalysis study was sent to HHS, suggesting ongoing regulatory discussion.

Seniors have been a focal point, with multiple outlets emphasizing September planning for older adults. Readers should monitor pharmacy inventory announcements for the exact launch date, as the initial rollout is described as “soon” by The Press Democrat. Health departments such as the Georgia Coastal Health District and local officials quoted by WHSV are expected to issue further guidance on timing and eligibility. Additional data may emerge from ongoing studies referenced by Technology Networks and 2 Minute Medicine, which could influence future CDC guidance. Tracking updates from the FDA and CDC will be key to understanding any changes to vaccine recommendations.